Patrick Lin, Chief Business - Strategy Officer at Processa Pharmaceuticals, Inc., purchased 1,603 shares of the company's stock. The transaction amounted to $4,063.
Processa Pharmaceuticals Officer Buys $4,063 in Company Stock
insider tradingpharmaceuticalsbiotechnologystock purchase
